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Abstract
Fatty Acid-Binding Proteins (FABPs) are abundant intracellular proteins that bind long chain fatty 
acids (FA) and have been related with inmunometabolic diseases. Intestinal epithelial cells express 
two isoforms of FABPs: liver FABP (LFABP or FABP1) and intestinal FABP (IFABP or FABP2). 
They are thought to be associated with intracellular dietary lipid transport and trafficking towards 
diverse cell fates. But still their specific functions are not well understood.
To study FABP1's functions, we generated an FABP1 knockdown model in Caco-2 cell line by 
stable antisense cDNA transfection (FABP1as). In these cells FABP1 expression was reduced up 
to 87%. No compensatory increase in FABP2 was observed, strengthening the idea of differential 
functions of both isoforms. In differentiated FABP1as cells, apical administration of oleate showed 
a decrease in its initial uptake rate and in long term incorporation compared with control cells. 
FABP1 depletion also reduced basolateral oleate secretion. The secreted oleate distribution showed 
an increase in FA/triacylglyceride ratio compared to control cells, probably due to FABP1’s role in 
chylomicron assembly. Interestingly, FABP1as cells exhibited a dramatic decrease in proliferation 
rate. A reduction in oleate uptake as well as a decrease in its incorporation into the phospholipid 
fraction was observed in proliferating cells.
Overall, our studies indicate that FABP1 is essential for proper lipid metabolism in differentiated 
enterocytes, particularly concerning fatty acids uptake and its basolateral secretion. Moreover, we 
show that FABP1 is required for enterocyte proliferation, suggesting that it may contribute to 
intestinal homeostasis.
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INTRODUCTION
Proximal intestinal epithelial cells express high levels of two fatty acid binding proteins 
(FABPs), liver FABP (LFABP or FABP1) [1] and intestinal FABP (IFABP or FABP2) [2,3]. 
FABPs are a family of intracellular proteins highly expressed in various tissues, with many 
tissues containing more than one FABP. FABP1, but not FABP2, is also highly expressed in 
hepatocytes and to a lesser extent in kidney, lung and pancreas [4]. FABP2 and FABP1 have 
been proposed to act as intracellular fatty acids (FA) transporters, potentially targeting FAs 
to different subcellular compartments and/or metabolic pathways according to their relative 
affinity and selectivity for different ligands. However, the specific functions of FABP2 and 
FABP1 have not yet been defined sufficiently so as to explain the presence of two isoforms 
of FABPs abundantly expressed in the same cell-type.
FABPs display almost superimposable backbone and secondary structure elements. 
Nevertheless, structure-function studies have determined several differences between them. 
FABP1 shows similar affinity for saturated and unsaturated FAs [5], and it binds up to two 
FAs as well as other ligands such as haem group, sterols, monoacylglycerols (MG), 
lysophospholipids,acyl-CoAs and endocannabinoids [1,6–8]. On the other hand, FABP2 has 
a single binding site for long chain FAs [9], preferentially saturated FAs [4,5]. Another 
interesting difference between intestinal FABPs is that they employ different mechanisms of 
FA transfer to and from model membranes [10,11].. To further elucidate enterocyte FABP 
functions, protein-protein interactions have been studied. It has been demonstrated that in 
hepatocytes FABP1 participates in the regulation of genes involved in lipid metabolism via 
delivery of FA to the transcription factors Peroxisome Proliferation-activated Receptors α 
(PPARα) and γ (PPARγ) [12,13]. In addition, FABP1 interacts with hepatocyte nuclear 
factor 4α (HNF4α), probably mediating inflammatory pathways in liver and intestine [14]. 
However, little is known about interactions of either FABP1 or FABP2 with other proteins in 
enterocytes.
The studies with null mice for FABP1 (Fabp1−/−) and FABP2 (Fabp2−/−) provide valuable 
models to analyze the importance of these proteins. No evidence of compensatory 
upregulation of FABP2 was found in intestinal mucosa in response to ablation of FABP1, 
and vice versa, in mice fed low fat diets [15]. Studies of Fabp2−/− mice indicated modest 
alterations in enterocyte lipid metabolism and no effects on bulk lipid absorption [15–18]. 
The changes observed in FABP1−/− mice are not completely conclusive. As noted above, 
FABP1 expression is found in several tissues and whether the changes in systemic 
metabolism are due to the absence of FABP1 in liver and/or in intestine is still unknown. 
Defects in hepatic FA oxidation, uptake, and VLDL secretion were observed in two models 
of Fabp1−/− mice [19–22]. Recent studies comparing Fabp2−/− and Fabp1−/− mice showed 
no effects on intestinal FA metabolism in FABP1−/− mice while it was observed that FABP2 
directs FA towards triglycerids (TG) synthesis [15]. In addition, mice with FABP1 ablation 
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showed that FABP1 participates in intestinal MG metabolism [15]. A direct comparison of 
Fabp2−/− and Fabp1−/− mice fed high fat diets also suggested that the two enterocyte 
proteins play different roles in intestinal and systemic metabolism [18]. Recent works 
indicate that Fabp1−/− mice shows impaired endocannabinoid system both in liver and in the 
brain [23,24].
Analysis of enterocyte FABPs in a more controlled physiological environment will give us 
further insight on their specific functions. In this work we used Caco-2 cells; although 
originally derived from a human adenocarcinoma [25] Caco-2 are, the most widely used 
model to study human intestinal epithelial cells, with well-characterized lipid metabolism 
[26–32] and many properties similar to proximal small intestinal enterocytes [33]. In spite of 
all the studies of FABP1, its functions in the enterocyte are not completely clear, so we 
developed a different strategy to explore this protein´s role. In the present study, we 
employed Caco-2 cells to stably knock down FABP1 and evaluate its participation in cellular 
processes. Since Caco-2 cells express very low if any FABP2, this model allowed us to 
evaluate cellular functions in the virtual absence of both proximal intestinal FABPs. Our 
results provide direct evidence that FABP1 is involved in the uptake of FA by intestinal 
epithelial cells. In addition, this protein participates in the basolateral secretion of lipids. 
Further, we show for the first time the importance of FABP1 in human enterocyte cell 
proliferation. Altogether, our results complement those obtained with transgenic mouse 




Lipofectamine, pcDNA3 plasmid, Geneticin, cell culture medium, and other culture reagents 
were from Invitrogen-Thermo Fischer Scientific (MA, US). Ultrafiltered fetal bovine serum 
(FBS) was from Natocor (Cordoba, Argentina). Restriction enzymes and other molecular 
biology reagents were from Promega (WI, US). [1-14C]oleic acid ([14C]-OA) and 
[6-3H]thymidine were from Amersham Biosciences-GE (MA, US). Fatty acid-free bovine 
serum albumin (BSA), mouse anti-β-actin monoclonal antibody, anti-mouse IgG peroxidase 
conjugate and anti-rabbit IgG peroxidase conjugate were purchased from Merck-Sigma 
(Darmstadt, Germany). Silica gel 60 chromatography plates and analytical-grade solvents 
were from Merck (Darmstadt, Germany).
Cell Culture
Caco-2 cell cultures were obtained from American Type Culture Collection and were grown 
as described previously [34]. Briefly, cells were cultured in high glucose Dulbecco’s 
Modified Eagle’s Medium (DMEM), 4 mM glutamine, 100 U/ml penicillin, and 100 pg/ml 
streptomycin and supplemented with 1 % nonessential amino acids, 1 % vitamins and 10 % 
fetal bovine serum in a 95 % air and 5 % CO2 atmosphere at 37 °C. For experiments, unless 
otherwise indicated, cells were plated onto polycarbonate Transwell filter inserts with 0.4 
µm pores (Corning Costar-Merck-Sigma, Darmstadt, Germany)at a density of 3×105 
cells/cm2, 5 times higher than the plating area, to ensure cells will be 100% confluent when 
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adhered to the filters They were maintained for 14–22 days postconfluence for 
differentiation, which was assessed by the increase in transmonolayer resistance with a 
Millicell-ERS unit (Merck- Millipore, Darmstadt, Germany). Only cells between passages 
58–80 were used.
Stable FABP1 Knockdown in Caco-2 Cells
The human FABP1 cDNA was generously provided by Dr. J. Veerkamp (Department of 
Biochemistry, University of Nijmegen, The Netherlands) and subcloned into a pcDNA3 in 
an antisense orientation employing BamHI and XbaI restriction sites. The construct 
pcDNA3- hFABP1as (hFABP1as for “human FABP1 antisense” cDNA) was transfected into 
Caco-2 cells using Lipofectamine 2000 reagent according to the manufacturer’s instructions. 
Positively transfected cells were selected with 1 mg/ml Geneticin in culture medium for 15 
days. Empty pcDNA3 vector was stably transfected into Caco-2 cells, and these cells were 
considered the control cell line. FABP1 antisense non-clonal (FABP1asNC) cell line was 
obtained as a heterogenous population after antibiotic selection. In order to obtain FABP1 
antisense clonal (FABP1asC) cell line the following protocol was used: cells were seeded at 
low density and colonies were isolated using cloning cylinders. Thus, FABP1asNC, 
FABP1asC and control were the stably transfected cell lines used for all the experiments 
described below. The use of Non-clonal cells dilutes differences caused by the random 
integration sites of the transfected DNA in the cell´s genome and represents more accurately 
the diversity of the parental cell line. The use of clonal populations, on the other hand, 
allows selecting those with the highest degree of modification (in this case, the lowest 
FABP1 expression). A combination of both approaches is for us the best design for more 
solid conclusions. For the selection of the genetically modified cell lines, 6 colonies were 
picked, but only 5 clones propagated to be screened. The ones employed in this work were 
chosen for their FABP1 knockdown levels (at least 70%) and proliferation rates high enough 
that would allow us to perform the assays in parallel with the control line.
Immunoblotting
Cells were lysed in 50 mM Tris-Cl, 150 mM NaCl buffer, pH 8 with 1 % NP-40 and 
protease inhibitors (Merck-Millipore-Darmstadt, Germany) (Lysis Buffer). The lysates were 
cleared by centrifugation and 30 µg of protein, resolved on 15 % SDS-PAGE, were 
transferred to PVDF membrane (Hybond, GE, MA, US). Rabbit anti-FABP1 and anti-
FABP2 serums, both produced in our laboratory [35] (1:5000 dilution) or monoclonal mouse 
anti-β-actin (1:10000 dilution) were used as primary antibodies. Goat anti-rabbit IgG or anti-
mouse IgG conjugated to horseradish peroxidase (1:10000 dilution) were used as secondary 
antibodies. Visualization was performed using a chemiluminescence detection kit 
(Supersignal West Pico -Pierce-Thermo Fischer Scientific, MA, US).
Cell Proliferation
To evaluate cell growth, 2×104 cells were seeded in duplicate 60-mm dishes. Twenty-four 
hours later, medium was removed and replaced with fresh growing medium. At this time and 
up to 264 h, cells were harvested by trypsinization and counted in a hemocytometer. 
Doubling time was estimated from the fitting of an exponential equation to the data. Cell 
viability was determined by Trypan Blue exclusion.
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Thymidine Incorporation into Total DNA
To measure the rate of DNA synthesis, cells grown in triplicate 60-mm dishes were pulsed 
with [6-3H]thymidine (0.5 µCi/dish) in 2 ml of growing medium for 3 h at 37 °C. Medium 
was removed and cell monolayers were washed twice with ice-cold PBS. DNA was 
precipitated with 0.5 % trichloroacetic acid for 10 min at 4 °C. The acid-insoluble material 
was solubilized with 0.1 N NaOH in 2 % Na2CO3 and an aliquot was counted in a liquid 
scintillation counter.
Preparation of fatty acid uptake medium
Oleic acid uptake medium was prepared as previously described [36,37]. Briefly, 
radiolabeled oleic acid was dried under N2 stream. The dried lipid was dissolved in 
concentrated oleic acid in ethanolic stock such that the amount of ethanol was less 0.5 % 
(V/V) at the final conditions. Oleic acid was then dispersed in 10 mM sodium taurocholate 
(TC) in PBS, pH 7.4, to obtain the desired concentration, and was further incubated for 1 h 
at 37 °C with shaking at 90 rpm to obtain a homogenous solution. The specific activities of 
the uptake solutions were 0.5–2 µCi/nmol. All solutions were used at 37 °C for uptake 
studies. In the case of oleic acid uptake medium for preconfluent undifferentiated cells 
grown in 60-mm dishes, 0.5 % BSA was used instead of TC.
Oleic Acid Uptake Assay
The initial rates of uptake of the TC-mixed FAs were determined over a range of ligand 
concentrations similarly to previous studies [37]. By using initial rates, only the uptake 
function is analyzed, with little or no subsequent metabolism of the fatty acid [29,36]. A 
saturable hyperbolic function was fitted to the data to obtain the apparent Michaelis-Menten 
constant (KM) and maximum velocity (Vmax) of the uptake processes. Analysis of the results 
was performed employing nonlinear regression analysis by Prism 4 (GraphPad Software), as 
previously described [36].
Metabolic Labeling
Preconfluent undifferentiated cells grown in 60-mm dishes were incubated for 2 min or 6.5 
hours with 0.4 µCi/dish [14C]oleic acid (100 µM oleic acid) in 0.5 % BSA in PBS. 
Differentiated cells grown onto polycarbonate Transwell filter inserts with 24 mm diameter 
0.4 µm pores were incubated for 2 min or 6.5 h with 0.4 µCi/dish [14C]oleic acid (100 µM 
oleic acid) in 10 mM TC in PBS in the apical compartment. The basolateral side of the 
transwell inserts contained complete medium with 10% FBS. Together, these conditions 
were chosen to emulate a postprandial state. After incubation, the uptake medium was 
removed, and the dishes or filters were immediately placed into an ice-cold 0.5 % BSA 
solution to stop cellular uptake and remove surface-bound fatty acid [38]. The dishes or 
filters were then rapidly washed once more with ice-cold 0.5 % BSA. After the BSA washes, 
the cells were washed three times with ice-cold PBS, scraped into PBS, and homogenized 
using a 27 G needle. Cell-associated radioactivity and total protein content were determined. 
In the case of differentiated cells, basolateral medium was also obtained in order to analyze 
secreted lipids. Lipid extraction was carried out as described by Bligh and Dyer [39]. Protein 
content was quantified by the Bradford protein assay, using BSA as a standard.
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Lipid Quantification and Analysis
Analysis of radioactivity of neutral lipid classes was carried out as described by Bagnato and 
Igal [40]. Briefly, neutral lipid classes were separated on silica gel 60 TLC plates using one-
dimensional single development procedures. Neutral lipids separation was carried out with 
hexane:ethylether:acetic acid, 80:20:2 (V/V) as solvent system. Lipid standards were seeded 
and run in parallel. For the [14C] labeling experiments, individual lipid spots detected by 
radiometric scanning (Storm 860, GE, MA, US) were scraped into plastic vials, and 
radioactivity levels were determined in a liquid scintillation counter. The amount of [14C] 
tracer incorporated in each lipid class was calculated from the specific activity of each 
substrate and normalized to cellular protein content.
Statistical Analysis
All experiments were performed at least in triplicate. Results are presented as means with 
the standard error of the mean (SEM). Statistical significance was first addressed by 
ANOVA and paired comparisons between samples were evaluated by Bonferroni´s 
correction of Student’s t test as a post hoc test (α = 0.05/N = 0.0167, for N = 3 paired 
comparisons).
RESULTS
FABP1 knockdown in Caco-2 cells
In order to analyze the role of FABP1 in enterocyte lipid metabolism, we generated a model 
of FABP1 depletion in Caco-2 cells. Caco-2 cells were stably transfected with a plasmid 
containing the human FABP1 cDNA in an antisense orientation (pcDNA3-hFABP1as) or 
with the empty vector (control cells). Anti-mRNA specificity was checked using nucleotide 
BLAST (National library of medicine, NCBI). Alignment of human FABP1 cDNA with 
human genome database showed only FABP1 as a possible target. After transfection, cells 
were selected with Geneticin (G418) antibiotic for 14 days to obtain clonal and non-clonal 
populations. The reduction of FABP1 levels in isolated populations of transfected cells was 
estimated by Western Blot. Figure 1A shows the reduction of 84 % and 87 % in FABP1 
content, relative to control cells (Control), in clonal (FABP1asC) and non-clonal 
(FABP1asNC) populations, respectively. No compensation with FABP2 expression was 
observed in these populations (Fig. 1B), supporting the hypothesis that these two proteins 
might have differential functions in intestinal epithelial cells.
FABP1 knockdown decreases oleic acid uptake rate and its total cellular incorporation
To determine whether the decrease in FABP1 levels was effectively translated into 
significant changes in lipid metabolism, FABP1 knockdown populations were tested for 
oleic acid (OA) uptake in differentiated cells grown onto polycarbonate Transwell filter 
inserts. To mimic the postprandial intestine, we simulated digested lipids mixing oleic acid 
with taurocholate (TC) as bile salt micellar solutions for apical uptake studies. Apical uptake 
of TC-mixed fatty acids is a linear function of time within 20 s and their metabolism during 
that timeframe is minimal [28]. Therefore, initial velocities of uptake were determined at 20 
s for various concentrations of OA. Uptake rates were plotted as a function of unbound 
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monomer and total concentration of OA (Fig. 2). In agreement with previous reports, the 
apical uptake of TC-mixed OA appeared to be, in part, a saturable function of the monomer 
FA concentration, suggesting that facilitated transport was occurring for the long-chain fatty 
acid [37]. The uptake profiles for OA in control, FABP1asC and FABP1asNC cells were 
well fit by a Michaelis-Menten function within the concentrations analyzed, and apparent 
KM and Vmax values were obtained from the best fit of the equation to oleate uptake rates 
(Table 1). The results show that KM values for FABP1as cells were significantly higher than 
for control cells (P < 0.0167), indicating a lower ability to assimilate oleate at low 
concentrations when FABP1 expression is diminished. However, estimated values of Vmax 
were similar for all cell lines, suggesting that the presence of membrane fatty acid 
transporters was not altered. FABP1. Overall, although FA entry to the enterocyte can occur 
either by passive diffusion or through membrane transporters, the amount of the intracellular 
protein FABP1 seems determinant to the rate and possibly the extent of uptake, highlighting 
the role of cytosolic transporters of FAs for their transport across membranes and cellular 
assimilation.
OA assimilation and metabolism were also studied at longer times of incubation to assess 
possible differences due to reduced expression of FABP1. It has been shown that after 360 
min incubation with OA, chylomicron assembly and secretion in Caco-2 cells is observed 
[33]. Therefore, differentiated cells were incubated apically with 100 µM [14C]-OA 
complexed with TC for short (2 min) and long (390 min) times, the latter selected to ensure 
OA metabolism and incorporation into chylomicrons. OA incorporated at 2 min (Fig. 3) was 
42% and 50% diminished compared to control cells in FABP1asC and FABP1asNC, 
respectively. At longer times of incubation significant reductions of 30% and 26% in OA 
incorporation into cellular lipid was observed in FABP1asC and FABP1asNC, respectively. 
No differences between clonal and non-clonal populations were detected. Thus, the 
reduction of FABP1 levels in human enterocytes dramatically diminishes total intracellular 
OA incorporation.
Radiolabeled OA was incorporated mainly in TGs and PL. No significant differences in OA 
distribution into different lipid classes were observed at any time (Supplemental Figure S1).
FABP1-deficient cells show altered composition of basolaterally secreted lipids
Assembly and secretion of chylomicron (CM) particles, synthesized only by intestinal 
epithelial cells, are essential for the transport of dietary fat and fat-soluble vitamins to the 
systemic circulation [33]. In fact, FABP1 is one of the proteins required to form the 
prechylomicron transport vesicle (PCTV) from the endoplasmic reticulum [41,42]. Caco-2 
cells differentiated on Transwell inserts showed high transepithelial resistance ensuring 
monolayer integrity. After apical incubation with [14C]-OA mixed with TC for 2 and 390 
min, basolaterally secreted lipids were collected and analyzed as described in ‘Materials and 
Methods’. Control cells secreted 4.7 ± 0.6 nmol of OA (calculated using [14C]-OA specific 
activity) and 27 ± 2 nmol of OA at 2 min and 390 min, respectively. By contrast, at brief 
incubation times FABP1as cells secreted 75% less and at long incubation times FABP1as 
cells secreted 25% less radiolabeled lipid (P < 0.0167) (Fig. 4). A percentage distribution 
between the incorporated and secreted radiolabel at 2 and 390 min shows that radiolabel 
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recovered from the basolateral medium, relative to that remaining in the cellular fraction, is 
decreased at short times but is compensated at long times (Supplemental Figure S2).
The incorporation of radiolabeled OA into basolaterally secreted lipid classes did not show 
differences between FABP1as populations and control cells following 2 minute incubations 
(Fig. 5A). At 390 min, however, significant differences in the distribution of [14C]-OA in 
secreted lipid classes were observed. In particular, clonal population of FABP1as exhibited a 
marked reduction of label incorporation in TG, while reduction in TG label in non-clonal 
population of FABP1as cells did not reached statistical significance. Both lines showed a 
larger proportion of radiolabel found as free fatty acids, compared to control cells (Fig. 5B). 
This observation is more pronounced in the clonal population, where cells are expected to 
have a more homogenous behavior.
These results support the importance of FABP1 not only in chylomicron biogenesis [20,43] 
but also in determining the content of secreted lipids.
Effects of FABP1 reduction on cell proliferation and differentiation
Given our observations that diminished FABP1 expression impairs OA assimilation and 
secretion, we addressed the question as to whether cell growth would be compromised by 
these alterations in lipid metabolism. Table 2 shows the doubling time calculated from 
growth curves for control cells, which is similar to previous reports for normal Caco-2 cells 
[32], 39 ± 2 h. FABP1as populations displayed a 20% slower growth rate than the control 
cells. It is important to note that there was no increase in the number of dead cells in either 
of the FABP1as cell lines, as evaluated by Trypan Blue exclusion (not shown). We next 
assessed the rate of DNA synthesis in these three populations by measuring [3H]thymidine 
incorporation into total cellular DNA. In agreement with the doubling time results, 
FABP1asC and FABP1asNC incorporated 50% less [3H]thymidine than control cells. Thus, 
both FABP1as cell populations had a significantly reduced synthesis of DNA when 
compared with control (Fig. 6).
Because FABP1 deficiency dramatically decreased the proliferation rate of these cell lines, 
we tested if other functions were altered, such us the differentiation rate. The measurement 
of transepithelial resistance (TEER) is indicative of tight junction formation and, hence, 
differentiation in Caco-2 cells [32]. We assessed the TEER of confluent monolayers of 
control and FABP1as cells daily for a period of 3 weeks, until all cells reached TEER > 
1000 Ω.cm2, when they are supposed to have completed the differentiation process [28]. No 
differences in the TEER measurements between control and FABP1as cells were observed 
(Supplemental material Fig. S3), suggesting unchanged differentiation rates.
Oleic acid incorporation and distribution into lipid classes in undifferentiated cells
To further investigate why the proliferation rate of FABP1as cells was diminished, we 
analyzed OA assimilation and distribution in undifferentiated proliferating cells. Figure 7 
shows total incorporation of OA after 2 and 390 min incubation. Although somewhat lower, 
the decrease in incorporation of OA by the FABP1as lines did not reach statistical 
significance at 2 min. However, as with the fully differentiated Caco-2 cells, OA assimilation 
into FABP1asC and FABP1asNC was significantly diminished after 390 min compared to 
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control line in the undifferentiated, proliferating cells. We then analyzed the distribution of 
[14C]-OA in lipid classes in these cells. There were no differences in the metabolism of 
radiolabeled OA in different lipid classes between FABP1as and control cells at short times 
of incubation (Fig. 8A). At 390 min, however, we observed that almost 80% of radiolabeled 
OA was incorporated into the TG fraction in FABP1 knockdown cells while incorporation 
into the PL fraction dramatically decreased, to less than 20% of [14C]-OA (Fig. 8B). The 
proportion of PL classes was not altered in LFABP1asC compared to control cells (data not 
shown). Control cells showed a reverse of this behavior, with 70% of radiolabeled OA 
incorporated in the PL fraction and less than 30% in the TG fraction.
DISCUSSION AND CONCLUSSION
Caco-2 is a model of human intestinal epithelial cells which offers the possibility of 
analyzing FABP1’s roles specifically in enterocytes-like cells. By contrast, studies 
employing whole animals, where FABP1 is abundantly expressed in several tissues, render 
results which are more difficult to interpret as enterocyte-specific. In this work, we 
generated clonal and non-clonal cell populations with >80% diminished FABP1 expression; 
no compensation by FABP2 was found, similar to observations in Fabp1−/− mice [15,20,44].
It was noted previously that both intestinal FABPs are localized mainly on the apical side of 
the enterocytes of fasted rats, suggesting that FABP1 and FABP2 may participate in FA 
uptake [43]. In our studies, FABP1 knockdown diminished the initial rate of cellular OA 
uptake, suggesting that the amount of FABP1 expressed in the enterocyte modulates the 
affinity for this ligand as well as cellular FA transport. These results are in agreement with 
previous studies using L-cells (murine fibroblasts) overexpressing FABP1, where the initial 
rate of cellular FA uptake was increased [45,46]. On the other hand, it is interesting to note 
that FABP2 overexpression in L-cell fibroblasts did not increase FA uptake as demonstrated 
by the same group of investigators [47], confirming that FABP2 functions are distinct from 
those of FABP1 transfected L-cells [45]. What is more, impaired OA incorporation was 
maintained for incubations longer than the equivalent to a postprandial period in FABP1asC 
and FABP1asNC cell lines compared to control cells, highlighting FABP1’s role in FA 
uptake from the intestinal lumen, probably interacting with membrane FA transport proteins, 
as suggested by the saturable function. Moreover, these results from Caco-2 cell system are 
supported by in vitro studies that indicate that FABP1 preferentially interacts with 
membranes in its apo-form [48] and stimulates fatty acid desorption from membranes, 
membrane FA loading [11], and FA transfer [49]. Taken together, these studies suggest that 
FABP1 is actively participating in FA removal from apical membranes and/or apical 
membrane FA transporters, stimulating enterocyte FA uptake.
Total lipid secretion into the basolateral space by FABP1asC and FABP1asNC was 
diminished relative to control cells. Moreover, there was a dramatic change in the 
distribution of OA into different lipid classes at 6.5h, with a reduction in incorporation into 
TG and an increase in the free FA fraction in FABP1asNC, and these changes were even 
more dramatic in FABP1asC cells. These results reveal the importance of FABP1 in the 
basolateral secretion of lipids. The fact that FABP1 is part of the prechylomicron transport 
vesicle (PCTV) and participates in its assembly, likely explains the observed decrease in 
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secreted lipids [41]. The low expression of FABP1 could compromise the appropriate 
assembly of the PCTV, as well as its composition, thus resulting in defects in chylomicron 
secretion by FABP1 knockdown cells. The decrease in TG correlated with an increase in free 
FA percentage distribution within secreted lipids. We hypothesize that FABP1 carrying FA 
would be interacting with enzymes that catalyze TG synthesis to form the lipid-protein 
complex which will be ultimately be secreted as chylomicrons to the lymph, and that in the 
absence of FABP1 normal chylomicron biogenesis and secretion is disrupted.
Although further experiments are necessary to test the specific roles of FABP1 in 
enterocytes, we have demonstrated that this protein participates in several cell processes 
including FA assimilation and its subsequent metabolism and secretion. Decreased FABP1 
levels also appear to delay cell growth in clonal and non-clonal FABP1as populations, as 
evidenced by longer population doubling times and lower thymidine incorporation into 
DNA. We also observed a reduction in the OA assimilation at long incubation times in 
proliferating cells. Importantly, a decrease in OA incorporation into the PL fraction was 
observed in undifferentiated FABP1as cells. This result is in accordance with previous 
reports showing that murine fibroblasts overexpressing FABP1 had increased incorporation 
of FAs into PL [50]. Other works performed in heart fatty acid binding protein (FABP3) 
gene-ablated mice also demonstrated that FABPs may target unsaturated FA to PL fraction 
[51]. The increase in the doubling time and the reduction in OA uptake may be associated; 
the reduced availability of building blocks for phospholipid membrane synthesis may 
explain the delay in growth observed in FABP1 knockdown cells. In line with this 
hypothesis, previous works from other authors have demonstrated that FABP1 may play a 
role in the modulation of hepatocyte growth [52–54]. It was previously reported that the 
knockdown of epidermal FABP (FABP5) [55] or brain FABP (FABP7) [56] drastically 
reduced the expansion of cells projections. Particularly, FABP7 was found to participate in 
growth cone regulation [56], which is responsible for axon guidance and synaptogenesis in 
mature neurons. In addition, it was observed that in an hyperproliferative context FABP1 
expression is upregulated in intestinal epithelial cells [35]. Thus, as observed for other 
members of the FABP family, our results indicate that FABP1 is necessary for enterocyte 
proliferation, although the molecular mechanisms underlying this process remain to be 
elucidated.
FABP1 participates in the regulation of the gene expression related to growth and cell 
differentiation, and a decrease in its expression could interfere with these processes. 
Interactions between FABP1 and nuclear receptor HNF4α [14] as well as the PPAR family 
[13] have been described. In the intestine, HNF4α is important for maintaining epithelial 
cell differentiation [57], lipid metabolism [58] and cell-cell junctions [59]. PPARs are 
nuclear receptors that activate the transcription of genes that encode a range of proteins 
involved in the regulation of lipid metabolism, as well as differentiation, inflammation, and 
cell survival [60,61]. Protein-protein interactions studies with transcription factors, in wild 
type cells as well as in this cell model with decreased FABP1, currently underway in our 
laboratory, will probably provide additional valuable information regarding FABP1 
participation in cell growth and metabolic processes.
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The results of the present report add important findings on the role of FABP1 in lipid 
metabolism in a human intestinal epithelial cell model, and raise new, interesting questions 
regarding its role in cell growth.
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Refer to Web version on PubMed Central for supplementary material.
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• FABP1 knock down model in Caco-2 cell line was generated.
• FABP1 is essential for proper lipid metabolism in differentiated enterocytes.
• FABP1 is required for enterocyte proliferation.
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Determination of FABPs protein levels in FABP1as cells. Preconfluent cells from control 
and clonal and non-clonal groups were harvested and resuspended in lysis buffer. Proteins 
were resolved by 15% SDS-PAGE, and the presence of FABP1 or FABP2 and β-actin was 
detected by Western blot and quantitated by densitometric analysis. 1FABP1 (A) or FABP2 
(B) levels were normalized to β-actin signal (upper line in both panels). The values represent 
the relative expression of FABP1 or FABP2 in FABP1as cells compared to control cells. 
Results are representative of 4 independent determinations; 30 µg of total cell protein was 
loaded per lane. Contrast and brightness of FABP2 Western blot was optimized for better 
visualization due to very low expression of this protein in Caco-2 cells.
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Initial rates of apical TC-mixed lipid uptake into Caco-2 cells. Caco-2 cells were incubated 
with TC-mixed radiolabeled lipid ([14C]-OA) for 20 s, and the intracellular radioactivity was 
measured. OA mass was calculated considering [14C]-OA specific activity. Results are 
expressed per total cellular protein content and uptake time (20 sec). Lines show the 
Michaelis-Menten fits for OA. Results are means ± SEM, n=4. * P < 0.0167 versus control.
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OA incorporation in differentiated Caco-2 FABP1 knockdown and control cells. 
Differentiated cells were incubated apically with 100 µM [14C]-OA complexed with TC for 
2 and 390 min. Cell lipids were extracted and radioactivity assessed as described in 
‘Materials and Methods’. Equivalents of OA mass was calculated using [14C]-OA specific 
activity, and results are expressed per mg of total cellular protein content. Results are means 
± SEM, n=3, * P < 0.0167 versus control.
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OA secretion in differentiated Caco-2 FABP1 knockdown and control cells. After apical 
incubation with 100 µM [14C]-OA complexed with TC for 2 and 390 min, basolateral 
medium was recovered. Lipids were extracted from recovered medium and radioactivity was 
assessed as described in ‘Materials and Methods’. OA mass was calculated using [14C]-OA 
specific activity and results were expressed as equivalents of AO mass per mg of total 
cellular protein content. Results are means ± SEM, n=3, * P < 0.0167 versus control.
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[14C]-OA secretion into lipid classes in FABP1 knockdown and control cells after incubation 
at different times. After apical incubation with 100 µM [14C]-OA complexed with TC for 2 
(A) and 390 (B) min, basolateral medium was recovered, and lipids were extracted and 
separated by TLC. Lipid spots corresponding to different classes were scraped, and their 
radioactivity was quantified. Radioactivity incorporated in each lipid fraction is expressed as 
percentage of total radioactivity incorporated. CE, cholesteryl esters; TG, triacylglycerols; 
FFA, free fatty acids; DG, diacylglycerols; MG, monoacylglycerols; PL, total phospholipids. 
Results are means ± SEM, n=3, * P < 0.0167 versus control.
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Thymidine incorporation into Caco-2 FABP1 knockdown and control cells. Control and 
FABP1as cells, grown in 60-mm dishes to 50% confluence, were pulsed with [3H]thymidine 
(1 µCi/dish) for 3 h at 37 °C. Cell monolayers were then precipitated with 5% trichloroacetic 
acid and the acid-insoluble material was counted. Results were expressed as incorporated 
dpm per total cellular protein content. Results are means ± SEM, n=3, * P < 0.0167 versus 
control.
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OA incorporation in undifferentiated Caco-2 FABP1 knockdown and control cells. 
Proliferating cells were incubated with 100 µM [14C]-OA with BSA for 2 and 390 min. Cell 
lipids were extracted and radioactivity assessed as described in ‘Materials and Methods’. 
Equivalents of OA mass was calculated using [14C]-OA specific activity, and results were 
expressed per mg of total cellular protein content. Results are means ± SEM, n=3, * P < 
0.0167 versus control.
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[14C]-OA incorporation into lipid classes after 2 and 390 min of incubation in 
undifferentiated FABP1 knockdown and control cells. Proliferating cells were incubated 
with 100 µM [14C]-OA with BSA for 2 (A) and 390 (B) min. Cell lipids were extracted and 
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separated by TLC. Lipid spots were scraped, and their radioactivity quantified. Radioactivity 
incorporated in each lipid class is expressed as percentage of total radioactivity incorporated. 
CE, cholesteryl esters; TG, triacylglycerols; FFA, free fatty acids; DG, diacylglycerols; MG, 
monoacylglycerols; PL, total phospholipids. Results are means ± SEM, n=3, * P < 0.0167 
versus control.
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Table 1
Apparent KM and Vmax values calculated from the Michaelis-Menten equation fitting to data.
KM(µM) Vmax(nmol/mg prot/20 sec)
Control 2.8 ± 0.2 7.1 ± 0.2
FABP1asNC 5.9 ± 0.3 * 6.0 ± 0.3
FABP1asC 6.3 ± 0.3 * 6.5 ± 0.2
*P < 0.0167 versus control.
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Table 2
FABP1 gene knockdown slows proliferation rate in Caco-2 cells. Doubling time of FABP1as and control cells.
Doubling time (h)
Control 39 ± 2
FABP1asNC 46 ± 1*
FABP1asC 47 ± 1*
*P < 0.0167 versus control.
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